(Q33514160)

27 July 2017

0 references

Evaluation of serological trials submitted for annual re-licensure of influenza vaccines to regulatory authorities between 1992 and 2002. (English)

1 reference

27 July 2017

1 reference

A C G Voordouw

1

1 reference

27 July 2017

W E P Beyer

2

1 reference

27 July 2017

D J Smith

3

1 reference

27 July 2017

M C J M Sturkenboom

4

1 reference

27 July 2017

B H Ch Stricker

5

1 reference

27 July 2017

language of work or name

English

0 references

publication date

28 October 2009

1 reference

27 July 2017

1 reference

27 July 2017

volume

28

1 reference

27 July 2017

issue

2

1 reference

27 July 2017

page(s)

392-397

1 reference

Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries.

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.138

Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.138

The Effect of Influenza Vaccination on IL2 Production in Healthy Elderly: Implications for Current Vaccination Practices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.138

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.138

Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.138

Impaired antibody response to influenza vaccine in institutionalized elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.138

Correlation between the antibody response to influenza vaccine and helper T cell subsets in healthy aging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.138

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.138

Exercise and psychosocial factors modulate immunity to influenza vaccine in elderly individuals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.138

Serum antibody response to influenza vaccine in pulmonary patients receiving corticosteroids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.138

Immune function and vaccine responses in healthy advanced elderly patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.138

Meta-analysis in clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.138

Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.138

Correlation between Rate of Infection and Preexisting Titer of Serum Antibody as Determined by Single Radial Hemolysis during an Epidemic of Influenza A/Victoria/3/75

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.138

A graded-dose study of inactivated, surface antigen influenza B vaccine in volunteers: reactogenicity, antibody response and protection to challenge virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.138

Interpretation of responses and protective levels of antibody against attenuated influenza A viruses using single radial haemolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.138

Virosomal influenza vaccine: a safe and effective influenza vaccine with high efficacy in elderly and subjects with low pre-vaccination antibody titers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.138

Comparison of the safety, tolerability, and immunogenicity of a MF59-adjuvanted influenza vaccine and a non-adjuvanted influenza vaccine in non-elderly adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.138

Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.138

FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10–11, 2007

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.138

10.1016/J.VACCINE.2009.09.138

7 January 2021

Identifiers

DOI

1 reference

27 July 2017

1 reference